Annual Cash & Cash Equivalents:
$453.00M+$141.34M(+45.35%)Summary
- As of today, HRMY annual cash & cash equivalents is $453.00 million, with the most recent change of +$141.34 million (+45.35%) on December 31, 2024.
- During the last 3 years, HRMY annual cash & cash equivalents has risen by +$218.69 million (+93.33%).
- HRMY annual cash & cash equivalents is now at all-time high.
Performance
HRMY Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$565.27M+$58.32M(+11.50%)Summary
- As of today, HRMY quarterly cash & cash equivalents is $565.27 million, with the most recent change of +$58.32 million (+11.50%) on June 30, 2025.
- Over the past year, HRMY quarterly cash & cash equivalents has increased by +$218.36 million (+62.95%).
- HRMY quarterly cash & cash equivalents is now at all-time high.
Performance
HRMY Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
HRMY Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +45.4% | +63.0% |
| 3Y3 Years | +93.3% | +122.4% |
| 5Y5 Years | +1752.2% | +641.0% |
HRMY Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +93.3% | at high | +83.7% |
| 5Y | 5-Year | at high | +1752.2% | at high | +300.4% |
| All-Time | All-Time | at high | +1752.2% | at high | +2211.3% |
HRMY Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $565.27M(+11.5%) |
| Mar 2025 | - | $506.95M(+8.5%) |
| Dec 2024 | $453.00M(+45.4%) | $467.19M(+13.8%) |
| Sep 2024 | - | $410.48M(+18.3%) |
| Jun 2024 | - | $346.91M(-6.8%) |
| Mar 2024 | - | $372.35M(+5.3%) |
| Dec 2023 | $311.66M(+27.8%) | $353.46M(-4.6%) |
| Sep 2023 | - | $370.67M(-0.1%) |
| Jun 2023 | - | $370.98M(+7.9%) |
| Mar 2023 | - | $343.88M(+6.4%) |
| Dec 2022 | $243.78M | $323.12M(+5.0%) |
| Sep 2022 | - | $307.76M(+21.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $254.17M(+13.2%) |
| Mar 2022 | - | $224.50M(-4.2%) |
| Dec 2021 | $234.31M(+2.5%) | $234.31M(+23.5%) |
| Sep 2021 | - | $189.70M(+18.8%) |
| Jun 2021 | - | $159.69M(+13.1%) |
| Mar 2021 | - | $141.17M(-38.3%) |
| Dec 2020 | $228.63M(+834.8%) | $228.63M(+3.1%) |
| Sep 2020 | - | $221.74M(+190.7%) |
| Jun 2020 | - | $76.28M(+6.7%) |
| Mar 2020 | - | $71.52M(+192.4%) |
| Dec 2019 | $24.46M(-70.7%) | $24.46M |
| Dec 2018 | $83.52M | - |
FAQ
- What is Harmony Biosciences Holdings, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Harmony Biosciences Holdings, Inc.?
- What is Harmony Biosciences Holdings, Inc. annual cash & cash equivalents year-on-year change?
- What is Harmony Biosciences Holdings, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Harmony Biosciences Holdings, Inc.?
- What is Harmony Biosciences Holdings, Inc. quarterly cash & cash equivalents year-on-year change?
What is Harmony Biosciences Holdings, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of HRMY is $453.00M
What is the all-time high annual cash & cash equivalents for Harmony Biosciences Holdings, Inc.?
Harmony Biosciences Holdings, Inc. all-time high annual cash & cash equivalents is $453.00M
What is Harmony Biosciences Holdings, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, HRMY annual cash & cash equivalents has changed by +$141.34M (+45.35%)
What is Harmony Biosciences Holdings, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of HRMY is $565.27M
What is the all-time high quarterly cash & cash equivalents for Harmony Biosciences Holdings, Inc.?
Harmony Biosciences Holdings, Inc. all-time high quarterly cash & cash equivalents is $565.27M
What is Harmony Biosciences Holdings, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, HRMY quarterly cash & cash equivalents has changed by +$218.36M (+62.95%)